Preview

Modern Rheumatology Journal

Advanced search

Evaluation of the efficacy of complex analgesic therapy, including a combination of B vitamins, in patients with combination of osteoarthritis and chronic non-specific low back pain (results of an open-label pilot clinical trial)

https://doi.org/10.14412/1996-7012-2024-2-56-61

Abstract

The vitamin B1, B6 and B12 complex (VBC) is frequently used to treat acute and chronic low back pain.

Objective: to investigate the effect of a combination of a non-steroidal anti-inflammatory drug (NSAID) and a VBC on the main manifestations of nociceptive system dysfunction in patients with combination of osteoarthritis (OA) and chronic non-specific low back pain (NSLBP).

Material and methods. The study group consisted of 99 patients (82% women, mean age 63.6±17.2 years) with OA of various localization and

NSLBP who had moderate to severe pain (≥4 on a numerical rating scale, NRS 0–10). All patients received etoricoxib 60 mg/day (up to 14 days) and a course of intramuscular (IM) injections of VBC (a drug for parenteral administration containing solutions of thiamine 100 mg, pyridoxine 100 mg, cyanocobalamin 1.0 mg and lidocaine 20 mg) 2.0 ml №10. Treatment outcome was assessed after 14 days.

Results and discussion. During treatment, the vast majority of patients showed a significant improvement: the median severity of pain on movement (NRS) decreased from 6.3 [5.0; 8.0] to 3.7 [3.0; 5.0], p=0.0001; functional impairment  –  from 3.8 [2.0; 6.0] to 2.2 [1.0; 3.0], p=0.001; fatigue – from 5.6 [4.0; 8.0] to 3.5 [0.0; 2.0], p=0.0001. 71.6% of patients rated the treatment results as good or excellent. Six patients had adverse reactions: 2 – local pain at the site of the intramuscular injections, 1 – arterial hypertension, 3 – epigastric pain. No serious adverse events were recorded.

Conclusion. The combined use of NSAIDs and VBC can provide significant improvement in patients with a combination of OA and NSLBP.

About the Authors

E. S. Filatova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

Ekaterina Sergeevna Filatova

34A, Kashirskoe Shosse, Moscow 115522



A. E. Karateev
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

34A, Kashirskoe Shosse, Moscow 115522



E. L. Shakhramanova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

34A, Kashirskoe Shosse, Moscow 115522



D. A. Ghukasyan
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

34A, Kashirskoe Shosse, Moscow 115522



S. Yu. Shkireeva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

34A, Kashirskoe Shosse, Moscow 115522



A.  M. Lila
V.A. Nasonova Research Institute of Rheumatology; Department of Rheumatology Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
Russian Federation

34A, Kashirskoe Shosse, Moscow 115522

2/1, Barrikadnaya Street, Build. 1, Moscow 125993



References

1. Nasonov EL, Yakhno NN, Karateev AE, et al. General principles of treatment for musculoskeletal pain: Interdisciplinary consensus. Nauchno-Prakticheskaya Revmatologiya. 2016; 54(3):247-265 (In Russ.)].

2. Veronese N, Cooper C, Bruyere O, et al. Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations. Drugs. 2022 Sep;82(13): 1347-1355. doi: 10.1007/s40265-022-01773-5. Epub 2022 Sep 16.

3. Trouvin AP, Perrot S. Pain in osteoarthritis.Implications for optimal management. Joint Bone Spine. 2018 Jul;85(4):429-434. doi: 10.1016/j.jbspin.2017.08.002. Epub 2017 Sep 6.

4. Moore RA, Moore OA, Derry S, et al. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Ann Rheum Dis. 2010 Feb;69(2):374-9. doi: 10.1136/ard.2009.107805. Epub 2009 Apr 12.

5. Moore AR, Smugar SS, Wang H, et al. Numbers-needed-to-treat analyses-do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials. Pain. 2010 Dec; 151(3):592-597. doi: 10.1016/j.pain.2010.07.013.

6. Paez-Hurtado AM, Calderon-Ospina CA,Nava-Mesa MO. Mechanisms of action of vitamin B1 (thiamine), B6 (pyridoxine), and B12 (cobalamin) in pain: a narrative review. Nutr Neurosci. 2023 Mar;26(3):235-253. doi: 10.1080/1028415X.2022.2034242.

7. Karaganis S, Song XJ. B vitamins as a treatment for diabetic pain and neuropathy. J Clin Pharm Ther. 2021 Oct;46(5):1199-1212. doi: 10.1111/jcpt.13375. Epub 2021 Feb 9.

8. Sambon M, Wins P, Bettendorff L. Neuroprotective Effects of Thiamine and Precursors with Higher Bioavailability: Focus on Benfotiamine and Dibenzoylthiamine. Int J Mol Sci. 2021 May 21;22(11):5418. doi: 10.3390/ijms22115418.

9. Calderуn-Ospina CA, Nava-Mesa MO. B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin. CNS Neurosci Ther. 2020 Jan; 26(1):5-13. doi: 10.1111/cns.13207. Epub 2019 Sep 6.

10. Barinov AN, Makhinov KA, Komarova OA. Preliminary results of the open multicenter all-Russian observation "MINERVA" (MILGAMMA in diseases of the nervous system and Algic syndromes). Russkii meditsinskii zhurnal. 2016;(24):1650-1656. (In Russ.)].

11. Parfenov VA. Treatment of acute non-specific back pain, the use of group B vitamins. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, neuropsychiatry, psychosomatics. 2022;14(6):98-102. (In Russ.)]. doi: 10.14412/2074-2711-2022-6-98-102.

12. Yu CZ, Liu YP, Liu S, et al. Systematicadministration of B vitamins attenuates neuropathic hyperalgesia and reduces spinal neuron injury following temporary spinal cord ischaemia in rats. Eur J Pain. 2014 Jan;18(1): 76-85. doi: 10.1002/j.1532-2149.2013.00390.x. Epub 2013 Sep 5.

13. Kopruszinski CM, Reis RC, Bressan E, et al. Vitamin B complex attenuated heat hyperalgesia following infraorbital nerve constriction in rats and reduced capsaicin in vivo and in vitro effects. Eur J Pharmacol. 2015 Sep 5;762:326-32. doi: 10.1016/j.ejphar.2015.05.063. Epub 2015 Jun 3.

14. Zolio L, Lim KY, McKenzie JE, et al. Systematic review and meta-analysis of the prevalence of neuropathic-like pain and/or pain sensitization in people with knee and hip osteoarthritis. Osteoarthritis Cartilage. 2021 Aug;29(8):1096-1116. doi: 10.1016/j.joca.2021.03.021. Epub 2021 May 8.

15. Schuttert I, Timmerman H, Petersen KK,et al. The Definition, Assessment, and Prevalence of (Human Assumed) Central Sensitisation in Patients with Chronic Low Back Pain: A Systematic Review. J Clin Med. 2021 Dec 17; 10(24):5931. doi: 10.3390/jcm10245931.

16. Ponce-Monter HA, Ortiz MI, Garza-Hernandez AF, et al. Effect of diclofenac with B vitamins on the treatment of acute pain originated by lower-limb fracture and surgery. Pain Res Treat. 2012;2012:104782. doi: 10.1155/2012/104782. Epub 2011 Oct 31.

17. Garza AF, Monroy-Maya R, Soto-Rios M,et al. A pilot study of the effect of diclofenac with B vitamins for the treatment of acute pain following lower-limb fracture and surgery. Proc West Pharmacol Soc. 2008;51:70-2.

18. Kim S. Overview of Clinical study design.Clin Exp Emerg Med. 2023 Jun 2. doi: 10.15441/ceem.23.036.

19. You S. Perspective and future of evidencebased medicine. Stroke Vasc Neurol. 2016 Dec 19;1(4):161-164. doi: 10.1136/svn-2016000032.

20. Bosdriesz JR, Stel VS, van Diepen M, et al. Evidence-based medicine-When observational studies are better than randomized controlled trials. Nephrology (Carlton). 2020 Oct;25(10):737-743. doi: 10.1111/nep.13742. Epub 2020 Jul 2.

21. Mahendraratnam N, Mercon K, Gill M,et al. Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product Effectiveness. Clin Pharmacol Ther. 2022 Jan;111(1): 150-154. doi: 10.1002/cpt.2272. Epub 2021 Jul 2.

22. Suri P, Morgenroth DC, Kwoh CK, et al.Low back pain and other musculoskeletal pain comorbidities in individuals with symptomatic osteoarthritis of the knee: data from the osteoarthritis initiative. Arthritis Care Res (Hoboken). 2010 Dec;62(12):1715-23. doi: 10.1002/acr.20324.

23. Coates G, Clewes P, Lohan C, et al. Chronic Low Back Pain with and without Concomitant Osteoarthritis: A Retrospective, Longitudinal Cohort Study of Patients in England. Int J Clin Pract. 2023 Nov 9;2023:5105810. doi: 10.1155/2023/5105810.

24. Calderon-Ospina CA, Nava-Mesa MO,Arbelaez Ariza CE. Effect of Combined Diclofenac and B Vitamins (Thiamine, Pyridoxine, and Cyanocobalamin) for Low Back Pain Management: Systematic Review and Metaanalysis. Pain Med. 2020 Apr 1;21(4):766-781. doi: 10.1093/pm/pnz216.

25. Mibielli MA, Geller M, Cohen JC, et al.Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr Med Res Opin. 2009 Nov;25(11):2589-99. doi: 10.3111/13696990903246911.

26. Magaсa-Villa MC, Rocha-Gonzalez HI,Fernandez del Valle-Laisequilla C, et al. B-vitamin mixture improves the analgesic effect of diclofenac in patients with osteoarthritis: a double blind study. Drug Res (Stuttg). 2013 Jun;63(6):289-92. doi: 10.1055/s-00331334963.

27. Dehghan M. Comparative effectiveness ofB and e vitamins with diclofenac in reducing pain due to osteoarthritis of the knee. Med Arch. 2015 Apr;69(2):103-6. doi: 10.5455/medarh.2015.69.103-106


Review

For citations:


Filatova ES, Karateev AE, Shakhramanova EL, Ghukasyan DA, Shkireeva SY, Lila AM. Evaluation of the efficacy of complex analgesic therapy, including a combination of B vitamins, in patients with combination of osteoarthritis and chronic non-specific low back pain (results of an open-label pilot clinical trial). Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2024;18(2):56-61. (In Russ.) https://doi.org/10.14412/1996-7012-2024-2-56-61

Views: 372


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)